NCJ Number
310575
Date Published
2025
Length
5 pages
Abstract
This report provides up-to-date information regarding the status of NPS benzodiazepine prevalence and positivity in the United States.
Novel psychoactive substances (NPS), including NPS benzodiazepines, continue to pose great challenges for forensic scientists, clinicians, and public health and safety personnel. NPS benzodiazepines have been implicated in an increasing number of adverse health events, marked by emergency room admissions and death investigations, especially when ingested in combination with opioids. Maintaining a current scope of analysis can be challenging, requiring comprehensive analytical methodologies and reference materials for identification(s). (Publisher abstract provided.)
Date Published: January 1, 2025
Downloads
Similar Publications
- Species Identification of Necrophagous Insect Eggs Based on Amino Acid Profile Differences Revealed by Direct Analysis in Real Time-High Resolution Mass Spectrometry
- SERS Biomedical Applications: Diagnostics, Forensics, and Metabolomics
- Approaches to Whole Mitochondrial Genome Sequencing on the Oxford Nanopore MinION